TY - BOOK ID - 125468179 TI - Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes PY - 2013 PB - Ottawa, Ontario : Canadian Agency for Drugs and Technologies in Health, DB - UniCat KW - Diabetes. KW - Evidence-based medicine. KW - Insulins therapeutic use. KW - Outcome assessment (Medical care) UR - https://www.unicat.be/uniCat?func=search&query=sysid:125468179 AB - ER -